Dare Bioscience
DARE
DARE
31 hedge funds and large institutions have $12.8M invested in Dare Bioscience in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
14% less funds holding
Funds holding: 36 → 31 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.7M | |
| 2 | +$283K | |
| 3 | +$104K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$67.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$56.5K |
Top Sellers
| 1 | -$271K | |
| 2 | -$126K | |
| 3 | -$40K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$35.9K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$23K |